CLASS II ONGOING Drug recall · Reported 11 Nov 2026 · FDA Enforcement Report

Delflex Peritoneal Dialysis Solution with 4.25% Dextrose recalled

Fresenius Medical Care Renal Therapies Group is recalling Delflex Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium/ Low Calcium and, distributed nationwide in the US. The recall was initiated on 14 Oct 2026 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 25NGPD001, Exp 4/30/2027
NDC46163-206, 46163-209, 46163-212
Quantity recalled116 cases (5 bags per case)

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0171-2027
FDA event ID
100130
Brand
Delflex
Manufacturer
Fresenius Medical Care de Mexico, S.A. de C.V.
Classification
Class II
Status
Ongoing
Recall initiated
14 Oct 2026
FDA classified
3 Nov 2026
Reported
11 Nov 2026
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility

Timeline

14 Oct 2026Recall initiated by company
3 Nov 2026Classified by FDA+20 days
11 Nov 2026Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

DELFLEX Peritoneal Dialysis Solution with 4.25% Dextrose, Low Magnesium/ Low Calcium and Attached stay safe Exchange Set, 2,500 mL Single dose bag, Sterile and Non-Pyrogenic, Rx only, CAT.NO. 054-25324. Fresenius Medical Care, Renal Therapies Group, LLC, Lawrence, MA 01843. NDC 46163-212-94

Where it was distributed

Nationwide in the USA.

Nationwide

Questions about this recall

Why was it recalled?

Lack of Assurance of Sterility:complaints have been received related to potential leaks from small perforations in the print area on the primary bag in the affected lots.

Which lots are affected?

Lot: 25NGPD001, Exp 4/30/2027

Where was it sold?

Nationwide in the USA.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 17 Nov 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

4 other products · FDA event 100130

More recalls from Fresenius Medical Care Renal Therapies Group

All 40

Other Dextrose recalls

All 42